BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
PTEN
,
nitric oxide metabolic process
,
Arthritis
,
Kidney
,
Nosology
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ceramide 1-phosphate binding
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Thalamus lateral nuclei
Globus pallidus
Substantia nigra pars compacta
Occipital lobe
Neutrophil of bone marrow
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Varicella-zoster virus infection
Tinea pedis
Disorder of iron metabolism
Pyloric ulcer
Allergy to substance
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Carbonyl Cyanide m-Chlorophenyl Hydrazone
P79 protein, human
Amino Acids, Peptides, and Proteins
AS 1842856
R-38486
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Relb
MIR30B
FLCN
IRF7
RTL1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
Comparison of soft tissue sarcoma gene signatures
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
Ovarian cancer cell lines expressing miR124 mimic or SIX4 siRNA
Mammary tumor MVT1 cells' lung metastases treated with GW2580
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for ceramide 1-phosphate binding
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ